BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cromsource Adds Early Phase Research Unit to its Portfolio


2/14/2012 9:14:48 AM

VERONA, Italy, February 13, 2012 /PRNewswire/ --

CROMSOURCE srl, an international full service contract research organisation (CRO) today announced the completion of an innovative private-public deal with Centro Ricerche Cliniche di Verona (CRC), a modern early phase clinical research unit, founded in 2005. The CRC is located in Verona and is now under state and CROMSOURCE ownership.

The early phase clinical research facilities of the CRC occupy about 800 square metres of the 8th floor of the G.B. Rossi Hospital in Verona. The CRC provides full overnight accommodation and is equipped to state-of-the-art levels. Staff at the CRC has extensive international Pharma experience and the CRC is fully integrated within the local medical and scientific community. This provides access to highly motivated, well-defined patient populations and disease groups for Proof-of-Concept studies.

'We are delighted to welcome CRC and its expert team,' stated Dr Oriana Zerbini, Chief Executive Officer of CROMSOURCE. 'For some time we have wanted to add early phase clinical trial capabilities to our comprehensive portfolio of services, and we have now found the perfect way to do so. With this collaboration CROMSOURCE truly becomes a full service CRO, able to provide our customers our support from the earliest part of their clinical development programmes.'

Dr Caffi, Chairman, Integrated University Hospitals of Verona, said 'our commitment to promoting international scientific research is further strengthened through this agreement with CROMSOURCE. Our full range of hospital services and facilities has always been available to CRC and we look forward to providing the same level of support to CROMSOURCE.'

Dr Stefano Milleri, Scientific Director of CRC noted 'for many years CRC has been proud to utilise our expertise and facilities to support the development of medicines on behalf of our clients. CROMSOURCE have a similar history and we share a philosophy of quality, flexibility and intense customer focus. We are therefore very excited to be joining the CROMSOURCE family.'

About CROMSOURCE: CROMSOURCE is an ISO certified, full-service Contract Research Organization providing clinical trial services and staffing solutions since 1994. CROMSOURCE delivers clinical trials across Europe, Russia, Ukraine and the USA. CROMSOURCE provides One Trial One Price - a fixed price guarantee which assures clients that each project will be delivered according to the contract price.

Contact: Margherita Mosconi
CROMSOURCE
Phone: +39-045-8222811
Fax: +39-045-8222812
Via Scuderlando, 10
37135 Verona, Italy

http://www.cromsource.com

SOURCE CROMSOURCE



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES